nVerses Capital’s CONMED CNMD Stock Holding History

nVerses Capital’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,000	Closed	-$144K	–	180
2024 Q3	$144K	Buy	2,000 +1,700	+567%	+$120K	0.07%	406
2024 Q2	$20.8K	Buy	300 +200	+200%	+$14.6K	0.01%	786
2024 Q1	$8.01K	Buy	+100	New	+$8.91K	0.02%	520

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

nVerses Capital's CNMD Position: Q4 2024 in Review

nVerses Capital sold out of CONMED (CNMD) in Q4 2024, closing a stake of 2,000 shares — an estimated $144K sold.

nVerses Capital first reported a position in CNMD in Q1 2024 and held it in 3 quarters. The position peaked at $144K in Q3 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

nVerses Capital reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 2,000 CONMED shares in Q4 2024, an estimated $144K.
nVerses Capital first reported a position in CONMED in Q1 2024 and held it in 3 quarters.
nVerses Capital's CONMED position peaked at $144K in Q3 2024.
280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.